Return to site

Needle-Free Injection System Market Projected to reach $20.17 Billion | Key players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S)

Growth Opportunities in Needle-Free Injection System

According to a new market research report Needle-Free Injection System Marketby Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) — Forecasts ”, published by MarketsandMarkets

The Global Needle-Free Injection System Market, in terms of value, is projected to reach USD 20.17 Billion, at a CAGR of 15.5% during the forecast period.

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Based on the technology, the Needle-Free Injection System Market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

Based on the end user, the Needle-Free Injection System Market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and another end user. The hospitals and clinics segment are expected to grow at the highest rate in the forecast period. The growth in this segment can primarily be attributed to the advancement in the medication or drug delivery technology and rising geriatric population.

Geographical Analysis:

The Needle-Free Injection System Market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market. Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe

The Needle Free Injection System Market is a fragmented market, with several big and emerging players.Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly